CO-OHD: Factors Associated With Failure of HFNO in COVID-19 ICU Patients

• Sponsor: Central Hospital, Nancy, France (Other)
• Overall Status: Not yet recruiting
• CT.gov ID: NCT05798234
• Collaborator: (none)
• Enrollment: 500
• Location: 1
• Anticipated Duration (Months): 7
• Patients Per Site Per Month: 71.1

Study Details

Study Description

Brief Summary

To determine the factors associated with OHD failure in COVID-19 patients admitted to an Intensive Care Unit

Condition or Disease	Intervention/Treatment	Phase
COVID-19 Pneumonia	Device: high flow oxygen device

Detailed Description

Patients admitted into 1 participating ICU for acute hypoxemic respiratory failure due to COVID-19 between 02/01/2020 and 06/01/2022 will be assessed for OHD failure

Study Design

• Study Type: Observational
• Anticipated Enrollment: 500 participants
• Observational Model: Cohort
• Time Perspective: Retrospective
• Official Title: Factors Associated With Failure of HFNO in COVID-19 ICU Patients
• Anticipated Study Start Date: May 1, 2023
• Anticipated Primary Completion Date: Sep 1, 2023
• Anticipated Study Completion Date: Dec 1, 2023

Outcome Measures

Primary Outcome Measures

1. High flow oxygen failure [icu stay duration]

   patients requiring initial high flow oxygen but finally intubated

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Patients admitted in ICU for COVID-19 pneumonia

Exclusion Criteria:

• under immediate ECMO

• secondary transferred from another ICU

• readmission in the ICU

• initial limitation of care

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Service de Réanimation Médicale, Hôpital Central	Nancy		France

Sponsors and Collaborators

• Central Hospital, Nancy, France

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Central Hospital, Nancy, France
• ClinicalTrials.gov Identifier: NCT05798234
• Other Study ID Numbers: 2022PI120
• First Posted: Apr 4, 2023
• Last Update Posted: Apr 4, 2023
• Last Verified: Apr 1, 2023

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: COVID-19

Study Results

No Results Posted as of Apr 4, 2023